BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32461138)

  • 1. High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
    de Bruyn JR; Bossuyt P; Ferrante M; West RL; Dijkstra G; Witteman BJ; Wildenberg M; Hoentjen F; Franchimont D; Clasquin E; van der Bilt JD; Tollens T; Bemelman WA; D'Hoore A; Duijvestein M; D'Haens GR;
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1573-1582.e5. PubMed ID: 32461138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
    Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
    Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
    Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
    Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.
    Ewe K; Böttger T; Buhr HJ; Ecker KW; Otto HF
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):277-82. PubMed ID: 10333200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.
    Bommelaer G; Laharie D; Nancey S; Hebuterne X; Roblin X; Nachury M; Peyrin-Biroulet L; Fumery M; Richard D; Pereira B; Goutte M; Buisson A;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1553-1560.e1. PubMed ID: 31470175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Narula N; Cooray M; Anglin R; Muqtadir Z; Narula A; Marshall JK
    Dig Dis Sci; 2017 Feb; 62(2):448-455. PubMed ID: 27975236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.
    Bayart P; Duveau N; Nachury M; Zerbib P; Gerard R; Branche J; Maunoury V; Wils P; Boruchowicz A; Boualit M; Laberenne JE; Manolache O; Desreumaux P; de Chambrun GP; Pariente B
    Dig Dis Sci; 2016 Oct; 61(10):2986-2992. PubMed ID: 27401274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated ileal blind loop inflammation after intestinal resection with ileocolonic anastomosis in Crohn's disease: an often neglected endoscopic finding with an unfavorable outcome.
    Beelen EMJ; de Vries AC; Bodelier AG; Moolenaar J; Schouten WR; van der Woude CJ
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1370-1375. PubMed ID: 31567617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
    J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
    Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study.
    de Barcelos IF; Kotze PG; Spinelli A; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; da Silva Kotze LM; Yamamoto T
    Colorectal Dis; 2017 Jan; 19(1):O39-O45. PubMed ID: 27943564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
    Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
    Rutgeerts P; Hiele M; Geboes K; Peeters M; Penninckx F; Aerts R; Kerremans R
    Gastroenterology; 1995 Jun; 108(6):1617-21. PubMed ID: 7768364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild neoterminal ileal post-operative recurrence of Crohn's disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions.
    Bachour SP; Shah RS; Lyu R; Rieder F; Qazi T; Lashner B; Achkar JP; Philpott J; Barnes EL; Axelrad J; Holubar SD; Lightner AL; Regueiro M; Cohen BL; Click BH
    Aliment Pharmacol Ther; 2022 May; 55(9):1139-1150. PubMed ID: 35285534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
    Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.